Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography Comparison with invasive technique by Hozumi, Takeshi et al.
CORONARY BLOOD FLOW
Noninvasive Assessment of Coronary Flow Velocity and Coronary Flow
Velocity Reserve in the Left Anterior Descending Coronary Artery by
Doppler Echocardiography
Comparison With Invasive Technique
TAKESHI HOZUMI, MD, KIYOSHI YOSHIDA, MD, FACC, TAKASHI AKASAKA, MD,
YOSHIO ASAMI, MD, YUMIKO OGATA, MD, TSUTOMU TAKAGI, MD, SHUICHIRO KAJI, MD,
TAKAHIRO KAWAMOTO, MD, YOSHIAKI UEDA, MD, SHIGEFUMI MORIOKA, MD
Kobe, Japan
Objectives. The purpose of this study was to evaluate whether
transthoracic Doppler echocardiography (TTDE) can reliably
measure coronary flow velocity (CFV) and coronary flow velocity
reserve (CFVR) in the left anterior descending coronary artery
(LAD) in the clinical setting.
Background. Coronary flow velocity measurement has provided
useful clinical and physiologic information. Advancement in
TTDE provides noninvasive measurement of CFV and CFVR in
the distal LAD.
Methods. In 23 patients, CFV in the distal LAD was measured
by TTDE (5 or 3.5 MHz) under the guidance of color Doppler flow
mapping at the time of Doppler guide wire (DGW) examination.
Coronary flow velocity in the distal LAD were measured at
baseline and hyperemic conditions (intravenous administration of
adenosine 0.14 mg/kg/min) by both TTDE and DGW techniques.
Coronary flow velocity reserve was defined as the ratio of peak
hyperemic to basal averaged peak velocity in the distal LAD.
Results. Clear envelopes of basal and hyperemic CFV in the
distal LAD were obtained in 18 (78%) of 23 study patients by
TTDE. There were excellent correlations between TTDE and DGW
methods for the measurements of CFV (averaged peak velocity:
r 5 0.97, y 5 0.94x 1 0.40; averaged diastolic peak velocity: r 5
0.97, y 5 0.94x 1 0.69; systolic peak velocities: r 5 0.97, y 5
0.91x 1 0.87; diastolic peak velocity: r 5 0.98, y 5 0.95x 1 1.10).
Coronary flow velocity reserve from TTDE correlated highly with
those from DGW examinations (r 5 0.94, y 5 0.95x 1 0.21).
Conclusions. Noninvasive measurement of CFV and CFVR in
the distal LAD using TTDE accurately reflects invasive measure-
ment of CFV and CFVR by DGW method.
(J Am Coll Cardiol 1998;32:1251–9)
©1998 by the American College of Cardiology
Coronary flow velocity (CFV) and coronary flow velocity
reserve (CFVR) measurements have provided useful clinical
and physiologic information (1–6). They have been assessed by
invasive or semiinvasive Doppler technique with a Doppler
catheter (7–15), a Doppler guide wire (DGW) (16–27), an
epicardial probe (28–32) and a transesophageal probe (33–35).
Transthoracic Doppler echocardiography (TTDE) is non-
invasive, relatively inexpensive and widely used in the clinical
setting. Several studies have reported that CFV in the left
anterior descending coronary artery (LAD) can be measured
using transthoracic two-dimensional and Doppler echocardi-
ography with a high-frequency transducer (36–42). A recent
study has shown CFV and CFVR in the distal LAD can be
measured by TTDE under the guidance of color Doppler flow
mapping (43). If CFV and CFVR can be reliably measured by
this noninvasive method, it would provide useful clinical
information. To our knowledge, however, CFV and CFVR
measurements in the distal LAD by TTDE have not been
validated with other established methods in the clinical setting
(44). Therefore, we designed this study to evaluate whether
TTDE can reliably measure CFV and CFVR in the distal
LAD.
Methods
Study patients. We examined 23 consecutive patients (12
men and 11 women; mean age 63 6 7 years) in whom CFV in
the distal LAD was measured by a DGW at the time of
coronary angiographic study. Exclusion criteria were as fol-
lows: acute myocardial infarction, unstable angina, atrial fibril-
lation, second-degree atrioventricular block, severe chronic
obstructive pulmonary disease or bronchospasm. All patients
underwent TTDE at the time of DGW examination. Thirteen
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patients had coronary artery disease (six patients with stenosis
in the proximal LAD, the remainder with angiographically
normal LAD), nine patients had valvular heart disease (four
patients with aortic regurgitation, three with mitral regurgita-
tion, one with mitral stenosis, one with aortic stenosis) and one
had dilated cardiomyopathy. All participants gave informed
consent to the protocol approved by the Committee for the
Protection of Human Subjects in Research at Kobe General
Hospital.
TTDE. The TTDE examinations were performed with a
digital ultrasound system (Acuson; Sequoia, Mountain View,
California) with a frequency of 5.0 or 3.5 MHz (Doppler
frequency, 5.0 or 3.5 MHz). In color Doppler flow mapping,
velocity range was set in the range of 6 8.9 to 6 24.0 cm/s. The
color gain was adjusted to provide the optimal images. Acous-
tic window was around the midclavicular line in the fourth and
fifth intercostal spaces in the left lateral decubitus position.
The ultrasound beam was transmitted toward the heart to
visualize coronary blood flow in the distal portion of the LAD
by color Doppler flow mapping. First, the left ventricle was
imaged in the long-axis cross-section; then the ultrasound
beam was inclined laterally. Next, coronary blood flow in the
distal LAD was searched under the guidance of color Doppler
flow mapping (Fig. 1). Positioning a sample volume (2.0, 2.5 or
3.0 mm wide) on the color signal in the distal LAD, Doppler
spectral tracings of flow velocity were recorded by fast Fourier
transformation analysis. Although we tried to align ultrasound
beam direction to distal LAD flow as parallel as possible, angle
correction was needed in each examination because of incident
Doppler angle (mean angle 39°, ranged from 30° to 54°). The
spectral Doppler of the LAD flow showed a characteristic
biphasic flow pattern with a larger diastolic component and a
small systolic one. All studies were recorded on 0.5-in. s-VHS
videotape for off-line analysis.
CFV and CFVR measurements by TTDE. Spectral Doppler
signal recordings by TTDE were obtained during DGW exam-
ination. We first recorded baseline spectral Doppler signals in
the distal LAD over five cardiac cycles at end-expiration by
TTDE immediately after recording them by the DGW method.
Intravenous adenosine was administered (0.14 mg/kg/min) to
obtain spectral Doppler signals during peak hyperemic condi-
tions. Immediately after Doppler signal recording during peak
hyperemia using a DGW, they were recorded by TTDE over
five cardiac cycles at end-expiration. A 12-lead surface electro-
cardiogram (ECG) and pressure waveform at the tip of the
guiding catheter inserted into the left main coronary artery
were monitored continuously.
Each study was analyzed by an experienced investigator
who was unaware of the other patient data. Measurements
were performed off-line by tracing the contour of the spectral
Doppler signal using the computer incorporated in the ultra-
sound system. Averaged peak velocities (APV), averaged
diastolic peak velocities (ADPV), averaged systolic peak ve-
locities (ASPV), diastolic peak velocities (DPV) at baseline,
and peak hyperemic conditions were measured from the
Doppler signal recordings (Fig. 2). Measurements were aver-
aged over three cardiac cycles. Coronary flow velocity reserve
was assessed as the ratio of peak hyperemic to basal APV.
Coronary angiography. Coronary angiography was per-
formed by the Judkins technique after intravenous injection of
4,000 IU of heparin. Coronary stenosis was evaluated using
multiple projections by an experienced investigator unaware of
the other data. Quantitative analysis was done using a MEDIS
(medical imaging systems) CMS analysis software (45–47).
DGW examinations. After routine cardiac catheterization,
coronary angiography and additional intravenous injection of
2,000 IU of heparin, a DGW was advanced into the LAD
through a 5-F coronary angiography catheter (Selecon; Clini-
cal Supply, Inc., Gifu, Japan). The DGW used in the present
study was 0.014 in. (0.36 mm), 175 cm long, flexible and
steerable, with a 15-MHz piezoelectric ultrasound transducer
integrated on the tip (Flowire; Cardiometrics, Inc., Mountain
View, California). The ultrasound beam diverges at 28° from
Abbreviations and Acronyms
ADPV 5 averaged diastolic peak velocity
APV 5 averaged peak velocity
ASPV 5 averaged systolic peak velocity
CFV 5 coronary flow velocity
CFVR 5 coronary flow velocity reserve
DGW 5 Doppler guide wire
DPV 5 diastolic peak velocity
LAD 5 left anterior descending coronary artery
TTDE 5 transthoracic Doppler echocardiography
Figure 1. TTDE (left) and schematic representation (right) showing
coronary blood flow (arrow) in the distal LAD. LV 5 left ventricle.
Figure 2. Measurements of variables of CFV recording. See text for
abbreviations in remaining legends.
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the transducer, and the sample volume was positioned at a
distance of 4.2 mm from the transducer. The tip of the DGW
was advanced to the distal portion of the LAD. An optimal
Doppler signal was obtained by moving the guide wire slightly
within the vessel lumen and adjusting the range gate control.
We confirmed the position of the tip of the DGW under
fluoroscopic monitoring and tried to set the tip of the DGW at
the same site of the sample volume at end-expiratory phase in
TTDE. Biphasic flow pattern with a larger diastolic component
and a small systolic one was recorded with the use of the DGW
and a velocimeter (FloMap; Cardiometrics, Inc.). During
DGW study, a 12-lead surface ECG and pressure waveform at
the tip of the guiding catheter were monitored continuously.
All studies were recorded on 0.5-in. s-VHS videotape for
off-line analysis.
CFV and CFVR measurements by the DGW. After Dopp-
ler signals were recorded in the distal LAD at baseline
condition, they were recorded to obtain the maximal velocity
during hyperemic conditions after the intravenous administra-
tion of adenosine (0.14 mg/kg/min). Averaged peak velocity,
ADPV, ASPV and DPV at baseline and peak hyperemic
conditions were measured from the Doppler signal recordings
by an experienced investigator who was unaware of the other
patient data. Measurements were averaged over three cardiac
cycles. Coronary flow velocity reserve was assessed as the ratio
of peak hyperemic to basal APV.
Analysis of CFV and CFVR data. Data are expressed as
mean value 6 SD. Linear regression analysis was used to
compare TTDE with the DGW method for the assessment of
APV, ADPV, ASPV, DPV and CFVR. An analysis of the
differences of the measurements was performed according to
the technique of Bland and Altman (48). To evaluate the effect
of observational variability on the measurement of APV,
ADPV, ASPV and DPV by TTDE, two independent observers
analyzed 10 randomly selected Doppler velocity recordings.
Each observer had no knowledge of the results of the other
observer and the CFV data by the DGW method. Interob-
server variability was calculated as the standard deviation of
the differences between the two observers, expressed as a
percent of the average value. Reproducibility was assessed in
seven patients who underwent CFV measurements by TTDE
twice, 10 min apart.
Results
Clear envelopes of basal and hyperemic CFV in the distal
LAD were obtained in 18 (78%) of 23 study patients by TTDE.
Table 1 shows a summary of clinical characteristics and CFV
and CFVR data in the 18 study patients.
CFV data. Figures 3 and 4 show an example of CFV
recording in the distal LAD obtained from TTDE and DGW
methods. There were excellent correlations between TTDE
and DGW methods for the measurements of APV, ADPV,
ASPV and DPV (r 5 0.97, y 5 0.94x 1 0.40, SEE 5 3.91 cm/s;
r 5 0.97, y 5 0.94x 1 0.69, SEE 5 4.20 cm/s; r 5 0.97, y 5
0.91x 1 0.87, SEE 5 2.84 cm/s; r 5 0.98, y 5 0.95x 1 1.10,
SEE 5 5.12 cm/s, Figs. 5 to 8). For APV, ADPV, ASPV and
DPV measurements, the mean differences between TTDE and
DGW methods were 21.42 6 3.98 cm/s, 21.59 6 4.31 cm/s,
20.87 6 3.01 cm/s and 21.72 6 5.21 cm/s, respectively (Figs.
5 to 8).
Interobserver variability and reproducibility. There was a
good agreement between the two independent observers’
measurements for APV, ADPV, ASPV and DPV (r 5 0.99,
r 5 0.99, r 5 0.99 and r 5 0.99). Interobserver variabilities for
APV, ADPV, ASPV and DPV were 4.2%, 3.9%, 4.5% and
4.9%, respectively. Reproducibility for APV, ADPV, ASPV
and DPV were 6.5%, 6.3%, 6.8% and 6.9%, respectively.
CFVR data. Coronary flow velocity reserve obtained from
TTDE correlated highly with those from DGW examinations
(r 5 0.94, y 5 0.95x 1 0.21, SEE 5 0.18, Fig. 9). The mean
difference between DGW and TTDE methods was 0.10 6 0.18
for CFVR measurements (Fig. 9).
Discussion
In the present study, we evaluated the reliability of CFV
and CFVR measurements in the distal LAD obtained from
TTDE, and demonstrated both CFV and CFVR measured by
this noninvasive method correlated highly with those by the
Figure 3. Example of CFV recordings at rest (left) and during
hyperemia (right) obtained from TTDE.
Figure 4. Example of CFV recordings at rest (left) and during
hyperemia (right) obtained from a DGW in the same patient in Figure
3.
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TTDE DGW TTDE DGW TTDE DGW TTDE DGW TTDE DGW TTDE DGW TTDE DGW TTDE DGW TTDE DGW
1 70 M AR 2 23.0 28.2 24.3 29.9 18.9 23.0 47.8 56.2 50.2 59.7 52.1 59.8 47.3 55.3 88.2 96.1 2.18 2.12
2 54 F Inferior MI 2 13.5 10.3 14.3 10.8 10.2 7.6 23.6 20.3 33.2 28.9 35.6 30.7 23.7 19.3 70.8 68.6 2.46 2.81
3 61 M MR 2 13.2 16.2 15.3 20.3 8.2 9.2 22.3 24.3 45.3 51.7 50.6 58.3 32.3 35.2 77.6 83.7 3.43 3.19
4 69 M Anterior
MI
1 Proximal: 48% 16.2 13.2 19.0 16.5 8.8 7.2 23.0 21.9 34.6 28.7 38.2 34.4 19.8 18.3 48.2 45.0 2.14 2.17
5 71 F DCM 2 19.7 17.5 21.4 20.8 17.0 16.0 30.7 29.1 41.2 36.5 46.4 43.0 34.5 32.3 58.2 56.8 2.09 2.09
6 54 M Inferior MI 2 17.7 24.3 21.8 27.1 8.1 12.2 29.7 35.7 41.2 54.0 51.0 62.7 20.7 28.2 79.8 89.3 2.33 2.07
7 64 M AP 2 7.9 7.3 9.2 8.2 6.3 5.2 14.6 12.9 18.2 15.1 20.8 17.4 11.7 9.4 33.2 27.3 2.30 2.07
8 57 M AR 2 20.7 24.2 22.5 27.6 15.1 17.0 40.5 47.0 30.7 32.5 32.8 37.0 22.0 25.0 57.2 63.4 1.48 1.34
9 66 F AS 2 20.4 18.0 21.8 19.2 13.7 11.2 34.3 30.2 42.5 39.6 48.6 45.2 25.6 23.2 66.4 64.3 2.08 2.20
10 55 M Inferior MI 1 Proximal: 43% 8.8 11.1 10.2 12.5 4.7 5.0 17.7 21.5 25.8 28.8 30.7 34.2 12.1 14.4 51.3 56.2 2.93 2.59
11 48 F AR 2 14.5 17.9 17.3 19.7 9.8 12.2 41.5 39.9 22.1 25.4 26.1 26.8 15.6 18.8 66.8 58.0 1.52 1.42
12 59 M MS 2 20.6 25.4 33.1 40.2 7.1 9.8 41.2 46.9 38.7 44.1 57.8 65.4 12.8 13.6 80.7 90.9 1.88 1.74
13 75 F AP 1 Proximal: 72% 23.3 26.4 27.8 28.3 15.8 17.8 39.8 40.6 40.8 44.8 45.8 49.2 36.5 40.3 61.2 67.5 1.75 1.70
14 52 F MR 2 33.1 29.7 40.4 36.2 18.3 16.8 55.2 50.8 87.8 84.2 95.3 90.2 40.2 35.2 129.0 120.0 2.65 2.84
15 69 F Inferior MI 1 Proximal: 21% 23.3 25.8 28.6 30.2 16.8 16.8 39.8 43.8 50.1 52.3 52.3 54.0 47.5 48.5 78.6 82.0 2.15 2.03
16 60 F AP 2 16.8 20.1 20.6 24.2 7.2 8.1 27.8 32.1 41.8 45.3 52.3 56.5 23.5 27.3 68.2 78.3 2.49 2.25
17 75 M MR 2 16.8 19.4 21.3 24.9 7.3 8.2 30.2 35.1 47.2 50.9 58.3 62.5 22.5 26.6 83.1 87.7 2.81 2.62
18 67 F AP 2 9.67 10.1 12.5 13.2 4.1 4.3 15.3 15.5 28.6 26.8 38.2 35.1 12.1 10.4 45.6 42.3 2.96 2.65
Mean 63 18.0 19.4 21.8 23.3 10.7 11.2 32.1 33.5 39.4 40.6 46.3 47.6 23.8 24.8 67.2 68.6 2.24 2.12
SD 8 6.4 6.7 8.3 8.8 4.9 4.8 11.4 11.7 16.2 16.5 17.7 18.3 11.2 11.2 22.4 23.3 0.47 0.44
ADPV 5 averaged diastolic peak velocity; AP 5 angina pectoris; APV 5 averaged peak velocity; AR 5 aortic regurgitation; AS 5 aortic stenosis; ASPV 5 averaged systolic peak velocity; CFVR 5 coronary flow velocity
reserve; DCM 5 dilated cardiomyopathy; DGW 5 Doppler guide wire; DPV 5 diastolic peak velocity; F 5 female; LAD 5 left anterior descending coronary artery; M 5 male; MI 5 myocardial infarction; MR 5 mitral





















































DGW method, which has already been validated for the
measurement of CFV.
CFV and CFVR measurements by invasive or semiinvasive
Doppler methods. Coronary flow velocity measurements have
provided useful clinical and physiologic information (1–6).
They have been assessed by several Doppler techniques with a
Doppler catheter (7–15), a DGW (16–27), an epicardial probe
(28–32) and a transesophageal probe (33–35). Doppler cath-
eter (7) and a DGW (17) already have been validated for the
measurement of CFV and CFVR and established as useful
techniques in the clinical setting. However, they are available
only in the catheterization laboratories. Transesophageal Dopp-
ler echocardiography is semiinvasive, although this approach is
available in echocardiographic laboratories (33–35). Thus, it
has been difficult to apply assessment of CFV to patients in
routine clinical practice.
CFV and CFVR measurements by TTDE. Transthoracic
Doppler echocardiography is noninvasive, relatively inexpen-
sive and widely used in the clinical setting, and can be used for
serial studies in echocardiographic laboratories. Several stud-
ies have reported that CFV can be measured by visualizing
LAD using transthoracic two-dimensional and Doppler echo-
cardiography with a high-frequency transducer (36–42). A
recent study has shown that CFV in the distal LAD can be
measured at high success rate by TTDE under the guidance of
color Doppler flow mapping, and assessment of CFVR in the
LAD by this noninvasive technique is useful in the diagnosis of
significant LAD stenosis (43). In the clinical study, however,
reliability of CFV and CFVR measurements by TTDE has not
been assessed yet. Only one animal study has reported
measurements of CFV and CFVR by TTDE during har-
monic contrast ultrasound imaging with simultaneous DGW
measurements (44). Therefore, in the present study, we
compared CFV and CFVR from TTDE in the clinical
setting with those from the DGW method, which has already
been validated (17).
All parameters representing CFV (APV, ADPV, ASPV
and DPV) measured from TTDE correlated highly with those
from the DGW method. These results suggest that CFV
recording in the distal LAD is reliable and available by TTDE
for the analysis of CFV characteristics. Furthermore, there is
an excellent correlation between the TTDE and DGW meth-
Figure 5. Regression (top) and difference (bottom) plots comparing
APV measured by TTDE and DGW methods.
Figure 6. Regression (top) and difference (bottom) plots comparing
ADPV measured by TTDE and DGW methods.
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ods for CFVR measurement. This suggests that reliable non-
invasive assessment of CFVR is possible in the echocardio-
graphic laboratories.
In the present TTDE technique, success rate in the mea-
surement of CFV in the distal LAD was high enough (78%) for
the clinical application. There were several reasons for a high
success rate in the present method. First, the reduction of the
velocity range enhanced the visualization of the low velocity
signal in the distal LAD by lowering the cut-off limit of the wall
motion filter. Velocity range in conventional color Doppler
flow mapping is usually set in the range from approximately
660 to 670 cm/s in routine echocardiographic examinations.
On the other hand, our present method lowered the setting of
the velocity range in color Doppler flow mapping (68.9 to
624.0 cm/s). Application of this newly modified velocity range
in color Doppler flow mapping provided improved visualiza-
tion of coronary flow signal in the distal LAD. Second, the
TTDE method under the guidance of color Doppler flow
mapping facilitated the positioning of the sample volume in
the distal LAD flow when compared with the previous
studies, which only employed two-dimensional imaging.
Finally, patients with chronic obstructive pulmonary disease
were not included in the present study, to avoid broncho-
spasm by intravenous infusion of adenosine. This study
population may contribute to high success rate in the
detection of CFV.
Advantages of TTDE. The present study demonstrated that
CFV and CFVR in the distal LAD can be assessed reliably and
noninvasively by TTDE under the guidance of color Doppler
flow mapping in the clinical setting. This noninvasive method
has some advantages. First, this method can be performed in
an outpatient setting because TTDE is widely available in the
clinical setting. Positron emission tomography provides nonin-
vasive measurements of CFV and CFVR (49–51). However, it
is an expensive and not generally available technique. Al-
though transesophageal Doppler echocardiography can be
used for CFV and CFVR measurement in echocardiographic
laboratories, it is semiinvasive (33–35). At the present time,
only TTDE provides noninvasive assessment of CFVR in
routine clinical practice.
Second, in patients with ischemic heart disease this tech-
nique has potential in the prediction of functional significant
coronary artery stenosis (33–35). A recent study has shown that
CFVR in the distal LAD obtained from TTDE has high
Figure 7. Regression (top) and difference (bottom) plots comparing
ASPV measured by TTDE and DGW methods.
Figure 8. Regression (top) and difference (bottom) plots comparing
DPV measured by TTDE and DGW methods.
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sensitivity and specificity in detecting significant LAD stenosis
(43).
Third, serial assessment can be performed by this technique
because it is noninvasive and relatively inexpensive. It may be
useful in the diagnosis of restenosis after coronary interven-
tion, such as percutaneous transluminal coronary angio-
plasty or stent implantation. Furthermore, pharmacologic
responses to CFV may be assessed serially by this noninva-
sive method.
Finally, it is possible to assess CFV or CFVR in routine
clinical practice in patients with aortic stenosis (13,14,52),
hypertrophic cardiomyopathy (15,53), hypertensive heart dis-
ease with left ventricular hypertrophy (54) and diabetes mel-
litus (25,55,56). Although characteristic CFV and CFVR have
been reported in various cardiac diseases in the previous
reports, they were assessed by a Doppler catheter, a DGW or
positron emission tomography. Noninvasive assessment of
CFV and CFVR by TTDE should be helpful in analyzing
coronary flow dynamics in these conditions.
Study limitations. The present study has some important
limitations. First, CFV and CFVR obtained from TTDE were
compared with those from the DGW method. Although the
DGW technique has been established for the assessment of
CFV and CFVR in the clinical settings, there is a limitation in
CFV measurement by this technique. The value of the peak
velocity is dependent on positioning of the wire, tortuous
segments and regions with varying luminal dimensions or
configurations (17). However, in the present study, we care-
fully positioned the tip of the guide wire to obtain a good signal
of CFV and measured CFV in the distal LAD, which does not
include the tortuous segment.
Second, it may be difficult to set the tip of a DGW at the
exact same site as the sample volume set in TTDE, although
we confirmed the location of the tip of a DGW under the
guidance of fluoroscopy. Especially in patients with a stenotic
lesion in the distal LAD, difference in the location of the
sample point in each method may affect the CFV measure-
ment. In the present method, however, CFV measurement by
a DGW was performed distal enough to the stenotic lesion in
patients with stenosis in the LAD because a DGW was
advanced to the distal LAD beyond the stenotic lesion.
Third, the present study consisted of a small number of
patients with each cardiac disease. However, the purpose of
the present study was to evaluate the reliability of CFV and
CFVR measurements by TTDE, not to evaluate the charac-
teristics of CFV and CFVR in various cardiac diseases. The
present results show excellent correlations and agreements for
the measurement of CFV and CFVR between the TTDE and
DGW methods. In future studies, larger numbers of patients
with various cardiac diseases should be examined by the
present method.
Conclusion. Noninvasive measurement of CFV and CFVR
in the distal LAD using TTDE accurately reflects invasive
measurement of CFV and CFVR by the DGW method.
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